Hospitals Zimmer Biomet Announces FDA Approval of Expanded 26-week Efficacy Claim for Gel-One® Cross-Linked Hyaluronate for Treatment of Pain Associated with Knee Osteoarthritis byJosh SandbergFebruary 2, 2017
Financial Hospitals Zimmer Biomet Announces Resolution with DOJ and SEC Regarding Previously Disclosed Legacy Biomet FCPA Matters byJosh SandbergJanuary 12, 2017
Financial Zimmer Biomet Announces Fourth Quarter and Full-Year 2016 Preliminary Sales Results byJosh SandbergJanuary 11, 2017
Financial Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2016 byJosh SandbergAugust 24, 2016
Financial Zimmer Biomet Holdings Announces Launch of Secondary Offering of Common Stock byJosh SandbergAugust 10, 2016
Spine Zimmer Biomet & NuVasive gain strong footholds in spine space: 7 things to note byJosh SandbergAugust 3, 2016
